MRI-Guided radiation trial aims to control tough lung cancers
NCT ID NCT03916419
Summary
This study tested whether using MRI guidance could make radiation treatment more precise for people with inoperable, advanced non-small cell lung cancer. Twenty-six participants received a combination of targeted radiation, chemotherapy, and an immunotherapy drug called durvalumab. The main goals were to see if this approach was safe and effective at controlling the cancer in the chest area.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE IIIA NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.